Association of reactive oxygen and nitrogen intermediate and complement levels with apoptosis of peripheral blood mononuclear cells in lupus patients

Arthritis and Rheumatism

Volumn 56, Issue 11, 2007, Pages 3738-3747

  Oates, James C ^a   Farrelly, Libby W ^a   Hofbauer, Ann F ^a   Wang, Wei ^a   Gilkeson, Gary S ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COBROTOXIN; DIETHYLENETRIAMINE; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; N ACETYL S NITROSOPENICILLAMINE; NITRATE; NITRIC OXIDE; NITRITE; PREDNISONE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN AND NITROGEN INTERMEDIATE; REACTIVE OXYGEN METABOLITE; RECOMBINANT COLONY STIMULATING FACTOR; UNCLASSIFIED DRUG;

ADULT; APOPTOSIS; ARTICLE; BLOOD SAMPLING; COMPLEMENT SYSTEM; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SERUM; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTIVIRAL AGENTS; APOPTOSIS; CELLS, CULTURED; COBRA VENOMS; COMPLEMENT INACTIVATING AGENTS; COMPLEMENT SYSTEM PROTEINS; FEMALE; HUMANS; INTERFERON-GAMMA; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; LONGITUDINAL STUDIES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; NITRIC OXIDE DONORS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES;

EID: 36048994256     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.22955     Document Type: Article

References (46)

1. Gaipl US, Kuhn A, Sheriff A, Munoz LE, Franz S, Voll RE, et al. Clearance of apoptotic cells in human SLE. Curr Dir Autoimmun 2006;9:173-87.
2. Ogden CA, Elkon KB. Role of complement and other innate immune mechanisms in the removal of apoptotic cells. Curr Dir Autoimmun 2006;9:120-42.
3. Navratil JS, Ahearn JM. Apoptosis, clearance mechanisms, and the development of systemic lupus erythematosus. Curr Rheumatol Rep 2001;3:191-8.
4. Mackawa Y, Yasutomo K. Defective clearance of nucleosomes and systemic lupus erythematosus. Trends Immunol 2001;22:662-3.
5. Emlen W, Niebur J, Kadera R. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol 1994;152:3685-92.
6. Richardson BC, Yung RL, Johnson KJ, Rowse PE, Lalwani ND. Monocyte apoptosis in patients with active lupus. Arthritis Rheum 1996;39:1432-4.
7. Herrmann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB, Kalden JR. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum 1998;41:1241-50.
8. Courtney PA, Crockard AD, Williamson K, Irvine AE, Kennedy RJ, Bell AL. Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: relations with disease activity, antibodies to double stranded DNA, and neutropenia. Ann Rheum Dis 1999;58:309-14.
9. Courtney PA, Crockard AD, Williamson K, McConnell J, Kennedy RJ, Bell AL. Lymphocyte apoptosis in systemic lupus erythematosus: relationships with Fas expression, serum soluble Fas and disease activity. Lupus 1999;8:508-13.
10. Perniok A, Wedekind F, Herrmann M, Specker C, Schneider M. High levels of circulating early apoptotic peripheral blood mononuclear cells in systemic lupus erythematosus. Lupus 1998;7:113-8.
11. Chan EY, Ko SC, Lau CS. Increased rate of apoptosis and decreased expression of bcl-2 protein in peripheral blood lymphocytes from patients with active systemic lupus erythematosus. Asian Pac J Allergy Immunol 1997;15:3-7.
12. Rumore PM, Steinman CR. Endogenous circulating DNA in systemic lupus erythematosus: occurrence as multimeric complexes bound to histone. J Clin Invest 1990;86:69-74.
13. Mohan C, Adams S, Stanik V, Datta SK. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J Exp Med 1993;177:1367-81.
14. Bell DA, Morrison B. The spontaneous apoptotic cell death of normal human lymphocytes in vitro: the release of, and immunoproliferative response to, nucleosomes in vitro. Clin Immunol Immunopathol 1991;60:13-26.
15. Mevorach D. The immune response to apoptotic cells. Ann N Y Acad Sci 1999;887:191-8.
16. Boyd CS, Cadenas E. Nitric oxide and cell signaling pathways in mitochondrial-dependent apoptosis. Biol Chem 2002;383:411-23.
17. Gilkeson G, Cannon C, Oates J, Reilly C, Goldman D, Petri M. Correlation of serum measures of nitric oxide production with lupus disease activity. J Rheumatol 1999;26:318-24.
18. Oates JC, Christensen EF, Reilly CM, Self SE, Gilkeson GS. Prospective measure of serum 3-nitrotyrosine levels in systemic lupus erythematosus: correlation with disease activity. Proc Assoc Am Physicians 1999;111:611-21.
19. Keng T, Privalle CT, Gilkeson GS, Weinberg JB. Peroxynitrite formation and decreased catalase activity in autoimmune MRL-lpr/lpr mice. Mol Med 2000;6:779-92.
20. Njoku CJ, Patrick KS, Ruiz P Jr, Oates JC. Inducible nitric oxide synthase inhibitors reduce urinary markers of systemic oxidant stress in murine proliferative lupus nephritis. J Investig Med 2005;53:347-52.
21. Oates JC, Gilkeson GS. Nitric oxide induces apoptosis in spleen lymphocytes from MRL/lpr mice. J Investig Med 2004;52:62-71.
22. Bijl M, Reefman E, Horst G, Limburg PC, Kallenberg CG. Reduced uptake of apoptotic cells by macrophages in systemic lupus erythematosus: correlates with decreased serum levels of complement. Ann Rheum Dis 2006;65:57-63.
23. Mosley K, Waddington SN, Ebrahim H, Cook T, Cattell V. Inducible nitric oxide synthase induction in Thy 1 glomerulone-phritis is complement and reactive oxygen species dependent. Exp Nephrol 1999;7:26-34.
24. Wang Y, He Q, Qin H, Xu J, Tong J, Gao L, et al. The complement C5b-9 complexes induced injury of glomerular mesangial cells in rats with Thy-1 nephritis by increasing nitric oxide synthesis. Life Sci 2006;79:182-92.
25. Matsuno R, Aramaki Y, Arima H, Adachi Y, Ohno N, Yadomae T, et al. Contribution of CR3 to nitric oxide production from macrophages stimulated with high-dose of LPS. Biochem Biophys Res Commun 1998;244:115-9.
26. Hochberg MC, for the Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997;40:1725.
27. Jungersten L, Edlund A, Petersson AS, Wennmalm A. Plasma nitrate as an index of nitric oxide formation in man: analyses of kinetics and confounding factors. Clin Physiol 1996;16:369-79.
28. Morrow JD, Frei B, Longmire AW, Gaziano JM, Lynch SM, Shyr Y, et al. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers: smoking as a cause of oxidative damage. N Engl J Med 1995;332:1198-203.
29. Brunner HI, Feldman BM, Bombardier C, Silverman ED. Sensitivity of the Systemic Lupus Erythematosus Disease Activity Index, British Isles Lupus Assessment Group Index, and Systemic Lupus Activity Measure in the evaluation of clinical change in childhood-onset systemic lupus erythematosus. Arthritis Rheum 1999;42:1354-60.
30. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, and the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992;35:630-40.
31. Isenberg D. Comparison of lupus activity indices. Clin Exp Rheumatol 1990;8 Suppl 5:37-40.
32. Darzynkiewicz Z, Bruno S, Del Bino G, Gorczyca W, Hotz MA, Lassota P, et al. Features of apoptotic cells measured by flow cytometry. Cytometry 1992;13:795-808.
33. Noguchi PD. Use of flow cytometer for DNA analysis. In: Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W, editors. Current protocols in immunology. New York: John Wiley & Sons; 1994. p. 5.7.
34. Ruijter JM, Thygesen HH, Schoneveld OJ, Das AT, Berkhout B, Lamers WH. Factor correction as a tool to eliminate between-session variation in replicate experiments: application to molecular biology and retrovirology. Retrovirology 2006;3:2.
35. Nagy G, Perl A. The role of nitric oxide in abnormal T cell signal transduction in systemic lupus erythematosus. Clin Immunol 2006;118:145-51.
36. 2+ signaling profile of lupus T cells. J Immunol 2004;173:3676-83.
37. Klint C, Truedsson L, Andreasson A, Johansson I, Sturfelt G. Toxic effects of SLE serum on normal monocytes in vitro: cell death induced by apoptosis related to complement dysfunction. Lupus 2000;9:278-87.
38. Fritzinger DC, Bredehorst R, Vogel CW. Molecular cloning and derived primary structure of cobra venom factor. Proc Natl Acad Sci U S A 1994;91:12775-9.
39. Vogel CW, Muller-Eberhard HJ. The cobra venom factor-dependent C3 convertase of human complement: a kinetic and thermodynamic analysis of a protease acting on its natural high molecular weight substrate. J Biol Chem 1982;257:8292-9.
40. Tsutsumi A, Takahashi R, Sumida T. Mannose binding lectin: genetics and autoimmune disease. Autoimmun Rev 2005;4:364-72.
41. Walport MJ, Davies KA, Botto M. C1q and systemic lupus erythematosus. Immunobiology 1998;199:265-85.
42. Russell AI, Cunninghame Graham DS, Shepherd C, Roberton CA, Whittaker J, Meeks J, et al. Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus. Hum Mol Genet 2004;13:137-47.
43. Goldstein JC, Kluck RM, Green DR. A single cell analysis of apoptosis: ordering the apoptotic phenotype. Ann N Y Acad Sci 2000;926:132-41.
44. 2+- and redox-dependent production of nitric oxide. J Immunol 2003;171:5188-97.
45. Zou MH, Shi C, Cohen RA. Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. J Clin Invest 2002;109:817-26.
46. Xia Y, Dawson VL, Dawson TM, Snyder SH, Zweier JL. Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc Natl Acad Sci U S A 1996;93:6770-4.